Table 1 Clinico-epidemiological characteristics and classification of treatment outcome of patients with recurrent infections
Patient Number | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
Age | 46 | 35 | 30 | 40 | 40 | 46 |
Gender | F | M | M | M | M | M |
Initial infection | ||||||
History of travel | Congo | Mozambique | Madagascar | Uganda | Congo | Central African Republic (CAR) |
Days from the onset of symptoms to diagnosis | 7* | 1 | 3 | 7 | 5 | 27* |
Days between arrival to diagnosis | 5 | 9 | 7 | 13 | 14 | 11 |
Parasitaemia (No. of parasites/µL) | 73,098 | 12,286 | 139,144 | 25,800 | 84,400 | 176 |
Clearance of parasitaemia | D1 | D1 | D2 | D2 | D2 | D1 |
Whether reactive surveillance conducted | Yes | Yes | Yes | Yes | Yes | Yes |
Recurrent infection | ||||||
Re appearance of parasitaemia | D16 | D19 | D19 | D28 | D18 | D105 |
Parasitaemia (µL−1) | 64 | 7,640 | 6,613 | 14,145 | 13,200 | 1,415 |
Clearance of parasitaemia | D1 | D1 | D2 | D2 | D2 | D2 |
History of travel | No | No | No | No | No | Yes (CAR) |
Risk of importation | High | High | High | Moderate | High | High |
Receptivity in the area | Low | Low | Low | High | Low | Moderate |
Whether reactive surveillance conducted | Only travel contacts screened | Only travel contacts screened | Only travel contacts screened | Only travel contacts screened | Both travel and geographical contacts | Both travel and geographical contacts |
Classification of recurrent infection | LCF/recrudescence | LCF/recrudescence | LCF/recrudescence | LCF/recrudescence | LCF/recrudescence | Reinfection |